Bortezomib in Treating Patients With Chronic Myelogenous Leukemia
Clinical trial NCT00023881 · TERMINATED
Trial details
- NCT number
- NCT00023881
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-07-02
- Primary completion
- 2005-03-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.